163 related articles for article (PubMed ID: 21865159)
21. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
[TBL] [Abstract][Full Text] [Related]
22. Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.
Geroldi D; Falcone C; Emanuele E
Curr Med Chem; 2006; 13(17):1971-8. PubMed ID: 16842191
[TBL] [Abstract][Full Text] [Related]
23. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
24. Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function.
Moroz OV; Burkitt W; Wittkowski H; He W; Ianoul A; Novitskaya V; Xie J; Polyakova O; Lednev IK; Shekhtman A; Derrick PJ; Bjoerk P; Foell D; Bronstein IB
BMC Biochem; 2009 Apr; 10():11. PubMed ID: 19386136
[TBL] [Abstract][Full Text] [Related]
25. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
Hori O; Brett J; Slattery T; Cao R; Zhang J; Chen JX; Nagashima M; Lundh ER; Vijay S; Nitecki D
J Biol Chem; 1995 Oct; 270(43):25752-61. PubMed ID: 7592757
[TBL] [Abstract][Full Text] [Related]
26. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
[TBL] [Abstract][Full Text] [Related]
27. Statins stimulate the production of a soluble form of the receptor for advanced glycation end products.
Quade-Lyssy P; Kanarek AM; Baiersdörfer M; Postina R; Kojro E
J Lipid Res; 2013 Nov; 54(11):3052-61. PubMed ID: 23966666
[TBL] [Abstract][Full Text] [Related]
28. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
Yamagishi S; Matsui T; Nakamura K
Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
[TBL] [Abstract][Full Text] [Related]
29. Soluble forms of RAGE in human diseases: clinical and therapeutical implications.
Santilli F; Vazzana N; Bucciarelli LG; Davì G
Curr Med Chem; 2009; 16(8):940-52. PubMed ID: 19275604
[TBL] [Abstract][Full Text] [Related]
30. EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes.
Huang SM; Chang YH; Chao YC; Lin JA; Wu CH; Lai CY; Chan KC; Tseng ST; Yen GC
Mol Nutr Food Res; 2013 Dec; 57(12):2264-8. PubMed ID: 23901023
[TBL] [Abstract][Full Text] [Related]
31. RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.
Ramasamy R; Yan SF; Schmidt AM
J Leukoc Biol; 2009 Sep; 86(3):505-12. PubMed ID: 19477910
[TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes.
Rasheed Z; Akhtar N; Haqqi TM
Rheumatology (Oxford); 2011 May; 50(5):838-51. PubMed ID: 21172926
[TBL] [Abstract][Full Text] [Related]
33. Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction.
Bonetti TC; Borges E; Braga DP; Iaconelli A; Kleine JP; Silva ID
Reprod Biomed Online; 2013 Jan; 26(1):62-7. PubMed ID: 23182743
[TBL] [Abstract][Full Text] [Related]
34. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.
Krechler T; Jáchymová M; Mestek O; Zák A; Zima T; Kalousová M
Clin Biochem; 2010 Jul; 43(10-11):882-6. PubMed ID: 20398646
[TBL] [Abstract][Full Text] [Related]
35. Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation.
Lanati N; Emanuele E; Brondino N; Geroldi D
Curr Vasc Pharmacol; 2010 Jan; 8(1):86-92. PubMed ID: 19485931
[TBL] [Abstract][Full Text] [Related]
36. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE).
Rani SG; Sepuru KM; Yu C
Biochim Biophys Acta; 2014 Sep; 1844(9):1718-28. PubMed ID: 24982031
[TBL] [Abstract][Full Text] [Related]
37. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.
Guo WA; Knight PR; Raghavendran K
Intensive Care Med; 2012 Oct; 38(10):1588-98. PubMed ID: 22777515
[TBL] [Abstract][Full Text] [Related]
38. Understanding RAGE, the receptor for advanced glycation end products.
Bierhaus A; Humpert PM; Morcos M; Wendt T; Chavakis T; Arnold B; Stern DM; Nawroth PP
J Mol Med (Berl); 2005 Nov; 83(11):876-86. PubMed ID: 16133426
[TBL] [Abstract][Full Text] [Related]
39. Circulating soluble RAGE and cell surface RAGE on peripheral blood mononuclear cells in healthy children.
García-Salido A; Melen G; Gómez-Piña V; Oñoro-Otero G; Serrano-González A; Casado-Flores J; Ramírez M
J Pediatr Endocrinol Metab; 2018 Jun; 31(6):649-654. PubMed ID: 29723156
[TBL] [Abstract][Full Text] [Related]
40. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]